DAPH ≥98% (by HPLC)
Proveedor: Enzo Life Sciences
ALEXBML-EI386-0005EA
181
EUR
ALEXBML-EI386-0005
DAPH ≥98% (by HPLC)
DAPH
DAPH abolishes or greatly reduces previously existing fully formed β-amyloid (1-42) fibrils and eliminates β-amyloid (1-42) peptide neurotoxicity. Also inhibits EGFR kinase. IC50 for inhibition of β-sheet content of aggregated β-amyloid (1-42) is 4.5µM.
- EGFR inhibitor
Orange solid.
Soluble in DMSO (25mg/ml).
Formula:
C₂₀H₁₅N₃O₂ MW: 329,4 Temperatura de almacenaje: Congelador |
Núm. CAS:
145915-58-8 |
Learn more

About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...